The founding team at Affinia Therapeutics has a history of experience in otolaryngology, research, and academia. The team is composed of individuals who have worked as an associate professor at the University of California, San Francisco, the chief scientific officer at Akouos, a researcher at the Broad Institute, and more. This team also has experience on the Board of Directors at Addgene and as an associate professor at Harvard Medical School. Furthermore, the team has a background in cellular and genetic biotechnology from Katholieke Universiteit Leuven.
View all